Table 2. Breast cancer risk associated with plasma leptin concentrations.
| Leptin level (ng ml−1) | No. of cases (%) | No. of controls (%) | Matched ORa (95% CI) | Adjusted ORb (95% CI) |
|---|---|---|---|---|
| All women | ||||
| <5.06 | 68 (22.9) | 147 (24.9) | 1.00 (reference) | 1.00 (reference) |
| 5.06–10.90 | 124 (41.8) | 299 (50.8) | 0.93 (0.63–1.38) | 0.87 (0.60–1.26) |
| >10.90 | 105 (35.3) | 143 (24.3) | 1.63 (1.07–2.49) | 1.58 (1.02–2.43) |
| Ptrend | 0.009 | 0.039 | ||
| Premenopausal | ||||
| <4.82 | 37 (21.5) | 83 (25.0) | 1.00 (reference) | 1.00 (reference) |
| 4.82–10.60 | 83 (48.3) | 168 (50.6) | 1.11 (0.68–1.75) | 0.99 (0.61–1.61) |
| >10.60 | 52 (30.2) | 81 (24.4) | 1.40 (0.83–2.38) | 1.63 (0.91–2.89) |
| Ptrend | 0.200 | 0.103 | ||
| Postmenopausal | ||||
| <5.20 | 28 (22.4) | 34 (24.9) | 1.00 (reference) | 1.00 (reference) |
| 5.20–11.50 | 47 (37.6) | 131 (50.9) | 0.78 (0.44–1.37) | 0.71 (0.40–1.26) |
| >11.50 | 50 (40.0) | 62 (24.2) | 1.69 (0.95–3.06) | 1.35 (0.70–2.60) |
| Ptrend | 0.050 | 0.324 | ||
CI=confidence interval; OR=odds ratio.
Odds ratios were matched on the date of enrolment and fasting status.
In addition to matched variables, odds ratios were also adjusted for body mass index and waist circumference.